- Home
- Publications
- Publication Search
- Publication Details
Title
Multiple myeloma
Authors
Keywords
-
Journal
Nature Reviews Disease Primers
Volume 3, Issue -, Pages 17046
Publisher
Springer Nature
Online
2017-07-20
DOI
10.1038/nrdp.2017.46
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial
- (2017) Brian G M Durie et al. LANCET
- Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies
- (2017) Cristina Ilcus et al. OncoTargets and Therapy
- Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma
- (2017) Nikhil C. Munshi et al. JAMA Oncology
- MUC1-C drives MYC in multiple myeloma
- (2016) Ashujit Tagde et al. BLOOD
- Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group
- (2016) P. Sonneveld et al. BLOOD
- Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy
- (2016) W I Gonsalves et al. BONE MARROW TRANSPLANTATION
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer Cell Dissemination and Homing to the Bone Marrow in a Zebrafish Model
- (2016) Antonio Sacco et al. CANCER RESEARCH
- Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies
- (2016) Camille Guillerey et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Patients with Multiple Myeloma
- (2016) F. Magrangeas et al. CLINICAL CANCER RESEARCH
- Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myeloma
- (2016) Salomon Manier et al. CURRENT OPINION IN HEMATOLOGY
- Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable?
- (2016) Merav Leiba et al. GENES CHROMOSOMES & CANCER
- Health-Related Quality-of-Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma
- (2016) A. Keith Stewart et al. JOURNAL OF CLINICAL ONCOLOGY
- Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial
- (2016) María-Victoria Mateos et al. LANCET ONCOLOGY
- International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
- (2016) Shaji Kumar et al. LANCET ONCOLOGY
- Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma
- (2016) J R Sawyer et al. LEUKEMIA
- Immunomodulatory drugs disrupt the cereblon–CD147–MCT1 axis to exert antitumor activity and teratogenicity
- (2016) Ruth Eichner et al. NATURE MEDICINE
- Genomic complexity of multiple myeloma and its clinical implications
- (2016) Salomon Manier et al. Nature Reviews Clinical Oncology
- Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
- (2016) Meletios A. Dimopoulos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
- (2016) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma
- (2016) David C. Johnson et al. Nature Communications
- Genome-wide association study identifies multiple susceptibility loci for multiple myeloma
- (2016) Jonathan S. Mitchell et al. Nature Communications
- Role of additional chromosomal changes in the prognostic value of t(4;14) and del(17p) in multiple myeloma: the IFM experience
- (2015) B. Hebraud et al. BLOOD
- Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?
- (2015) M.-L. Chretien et al. BLOOD
- Pathogenesis beyond the cancer clone(s) in multiple myeloma
- (2015) G. Bianchi et al. BLOOD
- Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers
- (2015) Xabier Agirre et al. GENOME RESEARCH
- Innovation in the field of thrombocytopenias: achievements since the beginning of the century and promises for the future
- (2015) C. L. Balduini et al. HAEMATOLOGICA
- European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
- (2015) E. Terpos et al. HAEMATOLOGICA
- V. Smoldering multiple myeloma
- (2015) María-Victoria Mateos et al. HEMATOLOGICAL ONCOLOGY
- Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma
- (2015) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
- (2015) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma
- (2015) Brian A. Walker et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic factors influencing the risk of multiple myeloma bone disease
- (2015) D C Johnson et al. LEUKEMIA
- The Cyclophilin A–CD147 complex promotes the proliferation and homing of multiple myeloma cells
- (2015) Di Zhu et al. NATURE MEDICINE
- Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
- (2015) Henk M. Lokhorst et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients
- (2015) Elad Ziv et al. Nature Communications
- Innovation in the field of thrombocytopenias: achievements since the beginning of the century and promises for the future
- (2015) C. L. Balduini et al. HAEMATOLOGICA
- European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
- (2015) E. Terpos et al. HAEMATOLOGICA
- The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma
- (2015) Elin Edda Sigurdardottir et al. JAMA Oncology
- Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma
- (2015) Neha Korde et al. JAMA Oncology
- Differential and limited expression of mutant alleles in multiple myeloma
- (2014) N. U. Rashid et al. BLOOD
- TPL2 kinase regulates the inflammatory milieu of the myeloma niche
- (2014) C. Hope et al. BLOOD
- Bortezomib-thalidomide-dexamethasoneversusbortezomib-cyclophosphamide-dexamethasone as induction therapy prior to autologous stem cell transplantation in multiple myeloma
- (2014) Philippe Moreau et al. BRITISH JOURNAL OF HAEMATOLOGY
- Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
- (2014) Jens G. Lohr et al. CANCER CELL
- miR-30-5p Functions as a Tumor Suppressor and Novel Therapeutic Tool by Targeting the Oncogenic Wnt/β-Catenin/BCL9 Pathway
- (2014) Jian-Jun Zhao et al. CANCER RESEARCH
- Prognostic Significance of Quantifying Circulating Plasma Cells in Multiple Myeloma
- (2014) Wilson I. Gonsalves et al. Clinical Lymphoma Myeloma & Leukemia
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
- (2014) S Vincent Rajkumar et al. LANCET ONCOLOGY
- The prognostic importance of the presence of more than one focal lesion in spine MRI of patients with asymptomatic (smoldering) multiple myeloma
- (2014) E Kastritis et al. LEUKEMIA
- Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma
- (2014) Lotfi Benboubker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Autologous Transplantation and Maintenance Therapy in Multiple Myeloma
- (2014) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Concise Review: Defining and Targeting Myeloma Stem Cell-Like Cells
- (2014) Masahiro Abe et al. STEM CELLS
- Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
- (2014) Niccolo Bolli et al. Nature Communications
- Control of Autophagic Cell Death by Caspase-10 in Multiple Myeloma
- (2013) Laurence Lamy et al. CANCER CELL
- Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma
- (2013) Chungyee Leung-Hagesteijn et al. CANCER CELL
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
- (2013) Jakob Lovén et al. CELL
- CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells
- (2013) Denise K Walters et al. CELL CYCLE
- BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression
- (2013) Aldo M. Roccaro et al. JOURNAL OF CLINICAL INVESTIGATION
- Chromosomal Abnormalities Are Major Prognostic Factors in Elderly Patients With Multiple Myeloma: The Intergroupe Francophone du Myélome Experience
- (2013) Hervé Avet-Loiseau et al. JOURNAL OF CLINICAL ONCOLOGY
- Myeloma Is Characterized by Stage-Specific Alterations in DNA Methylation That Occur Early during Myelomagenesis
- (2013) C. J. Heuck et al. JOURNAL OF IMMUNOLOGY
- Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
- (2013) S K Kumar et al. LEUKEMIA
- Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma
- (2013) S V Rajkumar et al. LEUKEMIA
- IMWG consensus on risk stratification in multiple myeloma
- (2013) W J Chng et al. LEUKEMIA
- Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013
- (2013) Joseph R. Mikhael et al. MAYO CLINIC PROCEEDINGS
- Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma
- (2013) María-Victoria Mateos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequent Engagement of RelB Activation Is Critical for Cell Survival in Multiple Myeloma
- (2013) Françoise Cormier et al. PLoS One
- Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
- (2013) J. Kronke et al. SCIENCE
- The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
- (2013) G. Lu et al. SCIENCE
- The Pathogenesis of Acute Kidney Impairment in Patients With Multiple Myeloma
- (2012) Vecihi Batuman ADVANCES IN CHRONIC KIDNEY DISEASE
- Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics
- (2012) S. Kumar et al. BLOOD
- CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease
- (2012) D. J. Dairaghi et al. BLOOD
- Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myeloma
- (2012) R. W. J. Groen et al. BLOOD
- Randomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma
- (2012) S. Kumar et al. BLOOD
- Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy
- (2012) M. Chesi et al. BLOOD
- Myeloma as a model for the process of metastasis: implications for therapy
- (2012) I. M. Ghobrial BLOOD
- Clonal competition with alternating dominance in multiple myeloma
- (2012) J. J. Keats et al. BLOOD
- Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models
- (2012) J. Hu et al. Disease Models & Mechanisms
- DangER: protein ovERload. Targeting protein degradation to treat myeloma
- (2012) L. I. Aronson et al. HAEMATOLOGICA
- Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial
- (2012) Pieter Sonneveld et al. JOURNAL OF CLINICAL ONCOLOGY
- A gene expression signature for high-risk multiple myeloma
- (2012) R Kuiper et al. LEUKEMIA
- Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
- (2012) Michel Attal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
- (2012) Philip L. McCarthy et al. NEW ENGLAND JOURNAL OF MEDICINE
- EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors
- (2011) A. G. Pallis et al. ANNALS OF ONCOLOGY
- Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)
- (2011) A. Palumbo et al. BLOOD
- Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3
- (2011) M. Dimopoulos et al. BLOOD
- Guidelines for supportive care in multiple myeloma 2011
- (2011) John A. Snowden et al. BRITISH JOURNAL OF HAEMATOLOGY
- Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicentre, randomised controlled trial
- (2011) James Berenson et al. LANCET ONCOLOGY
- Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma
- (2011) W-J Chng et al. LEUKEMIA
- A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial
- (2011) K D Boyd et al. LEUKEMIA
- Management of treatment-emergent peripheral neuropathy in multiple myeloma
- (2011) P G Richardson et al. LEUKEMIA
- Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
- (2011) S K Kumar et al. LEUKEMIA
- Impact of optimal follow-up of monoclonal gammopathy of undetermined significance on early diagnosis and prevention of myeloma-related complications
- (2010) G. Bianchi et al. BLOOD
- Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients
- (2010) A. Broyl et al. BLOOD
- Racial disparities in incidence and outcome in multiple myeloma: a population-based study
- (2010) A. J. Waxman et al. BLOOD
- The t(14;20) is a poor prognostic factor in myeloma but is associated with long-term stable disease in monoclonal gammopathies of undetermined significance
- (2010) F. M. Ross et al. HAEMATOLOGICA
- Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working Group
- (2010) Meletios A. Dimopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma
- (2010) Jens Hillengass et al. JOURNAL OF CLINICAL ONCOLOGY
- Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study
- (2010) Michele Cavo et al. LANCET
- Patterns of Multiple Myeloma During the Past 5 Decades: Stable Incidence Rates for All Age Groups in the Population but Rapidly Changing Age Distribution in the Clinic
- (2010) Ingemar Turesson et al. MAYO CLINIC PROCEEDINGS
- Management of disease- and treatment-related complications in patients with multiple myeloma
- (2010) Francesca Gay et al. MEDICAL ONCOLOGY
- Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity
- (2010) Douglas W McMillin et al. NATURE MEDICINE
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
- (2009) O. Landgren et al. BLOOD
- Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance
- (2009) C. M. Vachon et al. BLOOD
- MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma
- (2009) A. M. Roccaro et al. BLOOD
- Tandem Versus Single Autologous Hematopoietic Cell Transplantation for the Treatment of Multiple Myeloma: A Systematic Review and Meta-analysis
- (2009) A. Kumar et al. JNCI-Journal of the National Cancer Institute
- Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
- (2009) S Vincent Rajkumar et al. LANCET ONCOLOGY
- Infections in Patients With Multiple Myeloma
- (2009) Marcio Nucci et al. SEMINARS IN HEMATOLOGY
- Impact of early relapse after auto-SCT for multiple myeloma
- (2008) S Kumar et al. BONE MARROW TRANSPLANTATION
- Pathogenesis of myeloma bone disease
- (2008) G D Roodman LEUKEMIA
- IRF4 addiction in multiple myeloma
- (2008) Arthur L. Shaffer et al. NATURE
- Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
- (2008) Jesús F. San Miguel et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
- (2008) F. Pichiorri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More